article thumbnail

Highlights From the 2025 American Society for Mass Spectrometry Conference | By Jean-François Larocque and Benjamin Charron

Alta Sciences

With 6,000 scientists, students, and industry professionals from around the globe in attendance, it was an excellent opportunity to learn about the latest developments in mass spectrometry and share insights with other passionate scientists. Watch my presentation here : BIOANALYSIS INNOVATION AT ITS BEST!

article thumbnail

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

PoLiPa technology Domainex’s Polymer Lipid Particle (PoLiPa) technology offers a versatile, detergent-free platform for the rapid, high-purity preparation of membrane proteins like GPCRs, ion channels and solute carriers, enabling assay development for these challenging targets.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

k kh,h,,h, jjgm gmm

Twist Bioscience

Learn More > Variant Libraries Order Now TCR Libraries New Combinatorial Variant Library Spread Out Low Diversity Libraries Site Saturation Libraries Enzyme Screening Kits New Watch how Twist builds variant libraries for your perfect application Synthetic Controls Order Now Liquid Biopsy cfDNA Pan-Cancer Reference Standards v2 New Infectious Disease (..)

RNA 52
article thumbnail

Advancing Precision Oncology: Leveraging multidimensional biomarker insights with CGIP for efficient drug development and enhanced patient outcomes

Fierce BioTech

This presentation highlights Labcorp's latest innovations in precision oncology services. Additionally, we showcase the impact of a scalable, comprehensive assay developed under a thorough quality processes combined with a robust infrastructure in drug development. Click here to login.

article thumbnail

RNA processing in health and disease: challenges and opportunities of the field

Drug Target Review

His aims are to seek out the emerging therapeutic opportunities that RNA targets present and to develop effective methods to interrogate the underlying biology. Sam focuses on the application of innovative assay development strategies to enable to interrogation of complex targets.

RNA 96
article thumbnail

9th RSC-BMCS Fragment-based Drug Discovery Meeting

Zobio

ZoBio was represented by Pim de Vink (Scientist, Assay Development and Screening) who presented poster Screening for Fragment Molecular. The meeting focused on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs.

article thumbnail

9th RSC-BMCS Fragment-based Drug Discovery Meeting

Zobio

ZoBio was represented by Pim de Vink (Scientist, Assay Development and Screening) who presented poster Screening for Fragment Molecular. The meeting focused on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs.